Delivery Order SPE2DB20D2104-SPE2DB25FMKFT

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.56 firm fixed-price delivery order is for the supply of 4566150419 Progesterone 200 mg Capsule 100s, with an ultimate completion date of October 21, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, with ID SPE2DB24D1006|SPE2DB25FCEDY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,305.66 firm fixed-price delivery order is for the supply of 4567074495 - Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FANZ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,928.69 Firm Fixed Price contract is for the delivery of Progesterone 200 mg capsules to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, identified as SPE2DB22D1002|SPE2DB25FKXJ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.17, is for the delivery of 4567101124 - Progesterone 200 mg Capsules in 100-count packages. The contract has a completion date of January 31, 2025 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant...
This federal contract award, SPE2DB22D3010|SPE2DB25FP1UC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,886.98, is for the delivery of Progesterone 200 mg Capsule 100s, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 4, 2025. This award is part of a larger Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $21,249.50, is for the delivery of 4,567,254,676 units of Progesterone 200 mg capsules. The contract has a completion date of February 13, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $4,217.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566823701 - Progesterone 100 mg Capsule 100s, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB20D3304 and SPE2DB25FW5Q4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.46 firm fixed-price delivery order is for the supply of 4567445291 - Progesterone 200 mg Capsule 100s, with a period of performance through March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Defense Logistics Agency (DLA) awarded this $33,274.46 Firm Fixed Price Delivery Order for 4,567,038,407 units of Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Progesterone 200 mg Capsule 100s. The contract has a ceiling value of $4,039.88 and is a Firm Fixed Price Delivery Order contract. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMKFT
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMKFT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567459910 - Progesterone 200 mg Capsule 100s, with a firm fixed price of $9,144.58 and a completion date of March 5, 2025.

The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/3/25, 10:02 AM